Pricing Log in Create free account

Indaptus Therapeutics, Inc. (INDP) vs REGENXBIO Inc. (RGNX)

Indaptus Therapeutics, Inc. and REGENXBIO Inc. are both Biotechnology companies. Indaptus Therapeutics, Inc. and REGENXBIO Inc. are of similar size ($487.2M and $485.3M). Indaptus Therapeutics, Inc. has the higher net margin (0.00% vs −113.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Indaptus Therapeutics, Inc. leads on 7 and REGENXBIO Inc. on 5.

Valuation

Metric INDP RGNX Biotechnology median
P/E n/m n/m 10.60
P/S n/m 3.21 9.40
P/B 34.11 3.33 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 1.61 9.02
Earnings yield (231.90%) (42.52%) (32.88%)
Free cash flow yield (3.79%) (31.38%) (23.13%)

Profitability

Metric INDP RGNX Biotechnology median
Gross margin 0.00% 87.54% 68.51%
Operating margin 0.00% (95.68%) 0.00%
Net margin 0.00% (113.85%) 0.00%
Free cash flow margin 0.00% (100.58%) 0.00%
Return on equity (318.04%) (113.24%) (51.96%)
Return on assets (163.84%) (35.36%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric INDP RGNX Biotechnology median
Revenue growth (TTM) — (4.59%) 6.76%
EPS growth (last fiscal year) 52.15% 18.08% 29.88%
Revenue growth, 5-year CAGR — 1.97% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INDP RGNX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 19.48 4.74 4.97
Net debt to EBITDA 0.43 1.58 1.01

Dividend

Metric INDP RGNX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric INDP RGNX Biotechnology median
Market cap 485.32m 487.18m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack